Apexigen- Warrants (29/07/2027) Other Current Liabilities

As of the most recent data (June 2023), APGNW shows a other current liabilities of $5.4M. That compares with $3.8B in the prior-year period — down 99.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, APGNW's other current liabilities is now $5.4M (was $3.8B) — a 99.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Apexigen- Warrants (29/07/2027) is outperforming or lagging.

Tracking APGNW's other current liabilities over time shows whether Apexigen- Warrants (29/07/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $5.4M That compares with $3.8B in the prior-year period — down 99.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Apexigen- Warrants (29/07/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $5.4M) with ownership activity and broader fundamentals.